drugset / Trial / NCT00879346

A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets

NCT00879346

Phase 1 Completed 24 enrolled AstraZeneca
CrossoverOpen-labelBasic science

Summary

Phase I, randomised, open label, 3-period crossover study in healthy male subjects to investigate the effect of food on the pharmacokinetics of AZD8931 and to investigate the safety and tolerability of AZD8931.

Timeline

Start
2009-03
Primary completion
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject SAPITINIB Small molecule 160 mg Oral

Indications

No indication recorded.